|
|
|||||||
| Welcome to the Neuroscience Forum. | ||||
| Welcome to the Neuroscience Forum. If this is your first visit please register to be able to post and remove ads. To start viewing messages, select the forum that you want to visit from the selection below. |
 |
|
|
LinkBack | Thread Tools | Display Modes |
05-09-2009, 02:08 AM
|
#1 (permalink) |
|
Guest
Posts: n/a
|
Incidence Of PML With Tysabri In Multiple Sclerosis Lower Than Previously Thought
The risk of developing progressive multifocal leukoencephalopathy (PML), a viral brain infection, in patients with multiple sclerosis (MS) taking the drug natalizumab (Tysabri) appears to be much lower - and the infection less deadly - than previously estimated, according to new postmarketing surveillance data.
|
    
|
|
| Thread Tools | |
| Display Modes | |
|
|
Linear Mode
